Amalgamated Bank raised its holdings in Zoetis Inc. (NYSE:ZTS) by 2.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 59,268 shares of the company’s stock after purchasing an additional 1,324 shares during the quarter. Amalgamated Bank’s holdings in Zoetis were worth $3,779,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of ZTS. Strs Ohio raised its position in shares of Zoetis by 14.4% in the second quarter. Strs Ohio now owns 404,785 shares of the company’s stock worth $25,250,000 after acquiring an additional 51,087 shares during the period. FineMark National Bank & Trust acquired a new position in shares of Zoetis in the second quarter worth about $210,000. Park Avenue Securities LLC acquired a new position in shares of Zoetis in the second quarter worth about $252,000. Benjamin F. Edwards & Company Inc. raised its position in shares of Zoetis by 1.3% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 4,201 shares of the company’s stock worth $262,000 after acquiring an additional 55 shares during the period. Finally, IBM Retirement Fund raised its position in shares of Zoetis by 136.8% in the second quarter. IBM Retirement Fund now owns 12,031 shares of the company’s stock worth $838,000 after acquiring an additional 6,950 shares during the period. Institutional investors and hedge funds own 93.33% of the company’s stock.

A number of research analysts have weighed in on the stock. Morgan Stanley upgraded shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a research report on Wednesday. UBS reiterated a “neutral” rating on shares of Zoetis in a research report on Friday, November 24th. Cowen set a $80.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a research report on Friday, November 17th. Jefferies Group reiterated a “buy” rating on shares of Zoetis in a research report on Friday, November 10th. Finally, BMO Capital Markets upped their price target on shares of Zoetis from $65.00 to $70.00 and gave the stock a “market perform” rating in a research report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have given a buy rating to the company. Zoetis currently has an average rating of “Buy” and a consensus target price of $68.24.

Zoetis Inc. (ZTS) traded up $0.29 on Wednesday, hitting $71.68. 964,181 shares of the company traded hands, compared to its average volume of 2,786,177. Zoetis Inc. has a 52-week low of $48.55 and a 52-week high of $72.14. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. The firm has a market cap of $34,790.00, a P/E ratio of 32.70, a PEG ratio of 2.10 and a beta of 1.02.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.52 EPS. sell-side analysts expect that Zoetis Inc. will post 2.37 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Shareholders of record on Thursday, November 9th will be issued a $0.105 dividend. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 dividend on an annualized basis and a yield of 0.59%. Zoetis’s payout ratio is 22.11%.

TRADEMARK VIOLATION WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/11/29/amalgamated-bank-acquires-1324-shares-of-zoetis-inc-zts.html.

Zoetis Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.